Page 90 - Biotechnology Companies Segment Accounted For Largest Share News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology companies segment accounted for largest share. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Companies Segment Accounted For Largest Share Today - Breaking & Trending Today

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG. ....

Erin Duffy , Gary Schoolnik , Sexual Health Test , Drug Administration , Antibiotic Resistant Bacteria Biopharmaceutical , Visby Medical , Chief Medical Officer , Antimicrobial Resistance , Health And Human Services , Infectious Diseases , Inflammatory Disease , Mental Health , Pelvic Pain , Polymerase Chain Reaction , Public Health , Sexual Health ,

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research and Innovation's (UKRI) Technology Missions Fund, to develop novel vaccines, diagnostics and therapeutics. ....

United Kingdom , City Of , Iceni Glycoscience , Andrew Griffith , Brendan Wren , Quadram Institute , Glycocell Engineering Biology Mission Hub , School Of Life Sciences , London School Of Hygiene Tropical Medicine , Emission Award , University Of Exeter , United Kingdom Research , Vaccine Centre , Engineering Biology Mission Hubs , Technology Missions Fund , Synthace Limited Incepta Pharmaceuticals Ltd , University Of Dundee , University Of Nottingham , Imperial College London , Tropical Medicine , London School , Engineering Biology , Life Sciences , Glycocell Hub , Synthace Limited , Incepta Pharmaceuticals ,

| Agri-Pulse Communications, Inc.

Agri-Pulse is a trusted source in Washington, D.C., with the largest editorial team focused on food, fuel, fiber and farm policy coverage. Agri-Pulse presents a balanced perspective on a wide variety of issues. ....

Gabe Vasquez , Agriculture Organization , Agri Pulse , Arm Policy , Food Safety , Crop Insurance , Farm Bill , Pa Cftc ,

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

/PRNewswire/ DURECT Corporation (Nasdaq: DRRX) today announced that James E. Brown, President and Chief Executive Officer, will present at the Oppenheimer. ....

United States , Jamese Brown , Healthcare Life Sciences Conference , Innocoll Pharmaceuticals Ltd , Corporation Nasdaq , Drug Administration , Exchange Commission , Innocoll Pharmaceuticals , Chief Executive Officer , Annual Healthcare Life Sciences Conference , Fast Track , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Durect Corporation , Health Care Amp Hospitals , Medical Pharmaceuticals , Conference Call Announcements ,

Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million

The most expensive gene therapy on the US market may give payers pause, said study authors. ....

United States , Adamjn Raymakers , Liz Fowler , Department Of Dermatology , Division Of Pulmonary , Drug Administration , Program On Regulation , Innovation Center , Krystal Biotech , Critical Care Medicine , Gene Therapy Access Model , Biologic Therapy , Genomics Genomic Medicine , Gene Therapy , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Healthcare Technology , Medical Technology , Skin Cancer , Alignant Skin Neoplasm , Squamous Carcinoma , Squamous Cancer , Squamous Cell Carcinoma , Biomedical Technology ,